AnalystsReni J. Benjamin
Reni J. Benjamin's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 28%
#1446 out of 5263 analysts
Average Return
+7.07%
Win Rate
36%9 out of 25
Risk vs Reward
Poor
Good

Reni J. Benjamin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Prelude Therapeutics IncPRLD
+365.04%$0.94$4.39
2025-08-17 -
2026-04-28
Buy
Kura Oncology IncKURA
+59.39%$5.54$8.83
2025-08-10 -
2026-04-28
Buy
Summit Therapeutics IncSMMT
+46.82%$14.48$21.26
2026-01-29 -
2026-04-28
Buy
Bicara Therapeutics IncBCAX
+29.63%$16.91$21.92
2026-01-28 -
2026-04-28
Buy
Bicara Therapeutics IncBCAX
+10.21%$19.89$21.92
2026-03-30 -
2026-04-28
Buy

Reni J. Benjamin Analyst Color

Get additional color on Reni J. Benjamin's coverage of popular stocks

Reni J. Benjamin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Compass Therapeutics IncCMPX
1Buy$10.00+443.48%Reiterates
a day ago
Sutro Biopharma IncSTRO
2Buy$41.00+18.19%Maintains
6 days ago
Whitehawk Therapeutics IncWHWK
1Buy$8.00+93.70%Initiates Coverage On
13 days ago
Allogene Therapeutics IncALLO
1Buy$8.00+265.30%Maintains
15 days ago
Bicara Therapeutics IncBCAX
2Buy$31.00+41.42%Reiterates
a month ago
IMMIX Biopharma IncIMMX
1Buy$23.00+167.44%Reiterates
a month ago
Lyell Immunopharma IncLYEL
1Buy$34.00+58.21%Initiates Coverage On
2 months ago
Iovance Biotherapeutics IncIOVA
2Buy$5.00+47.93%Upgrades
2 months ago
Immutep LtdIMMP
2Buy$10.00+1,953.39%Initiates Coverage On
2 months ago
Summit Therapeutics IncSMMT
4Buy$40.00+88.15%Reiterates
3 months ago
Zymeworks IncZYME
1Buy$32.00+14.53%Initiates Coverage On
5 months ago
Beone Medicines LtdONC
1Buy$396.00+32.81%Maintains
6 months ago
Sana Biotechnology IncSANA
1Buy$8.00+138.81%Maintains
6 months ago
Kura Oncology IncKURA
2Buy$24.00+171.80%Reiterates
6 months ago
Werewolf Therapeutics IncHOWL
1Buy$3.00+305.41%Maintains
8 months ago
Prelude Therapeutics IncPRLD
1Buy$3.00-31.66%Maintains
8 months ago
Bicycle Therapeutics PLCBCYC
1Buy$10.00+113.22%Maintains
9 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.